"Lipids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D008055
|
| MeSH Number(s) |
D10
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipids".
- Chemicals and Drugs [D]
- Lipids [D10]
Below are MeSH descriptors whose meaning is more specific than "Lipids".
This graph shows the total number of publications written about "Lipids" by people in this website by year, and whether "Lipids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 1 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 6 | 6 |
| 2005 | 2 | 3 | 5 |
| 2006 | 1 | 2 | 3 |
| 2007 | 5 | 5 | 10 |
| 2008 | 2 | 4 | 6 |
| 2009 | 3 | 1 | 4 |
| 2010 | 0 | 3 | 3 |
| 2011 | 4 | 4 | 8 |
| 2012 | 2 | 2 | 4 |
| 2013 | 3 | 2 | 5 |
| 2014 | 3 | 6 | 9 |
| 2015 | 4 | 2 | 6 |
| 2016 | 3 | 7 | 10 |
| 2017 | 4 | 4 | 8 |
| 2018 | 1 | 4 | 5 |
| 2019 | 1 | 4 | 5 |
| 2020 | 2 | 2 | 4 |
| 2021 | 4 | 1 | 5 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 7 | 7 |
| 2024 | 0 | 2 | 2 |
| 2025 | 4 | 0 | 4 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipids" by people in Profiles.
-
Identification of lipid quantitative trait loci linked with cardiometabolic disease in Asian Indians and Europeans: A genome-wide association study and Mendelian randomization. PLoS Med. 2026 04; 23(4):e1005039.
-
Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. JACC Cardiovasc Imaging. 2026 Apr; 19(4):516-534.
-
Effect of obesity and exercise training on circulating lipids in American Indian adolescents. PLoS One. 2025; 20(12):e0338547.
-
Rationally designed sodium thiosulfate-loaded solid lipid nanoparticles for inner ear delivery and prevention of medication-induced ototoxicity. J Mater Chem B. 2025 Nov 19; 13(45):14690-14703.
-
Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease. Metabolomics. 2025 Oct 25; 21(6):153.
-
The Role of GPX Enzymes, Lipid Profiles, and Iron Accumulation in Necrotizing Enterocolitis. Int J Mol Sci. 2025 Jun 25; 26(13).
-
Sexual dimorphism in lipidomic changes in maternal blood and placenta associated with obesity and gestational diabetes: A discovery study. Placenta. 2025 01; 159:76-83.
-
Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance. Proc Natl Acad Sci U S A. 2024 Apr 23; 121(17):e2320934121.
-
Comparative mechanistic study of RPE cell death induced by different oxidative stresses. Redox Biol. 2023 09; 65:102840.
-
Clustering of cardiometabolic risk factors in Mexican pre-adolescents. Diabetes Res Clin Pract. 2023 Aug; 202:110818.